Account
FCB Ulka bags SBI Mutual Fund’s creative duties
MUMBAI: In a recent development, SBI Mutual Fund, the fifth largest (by AUMs) asset management company in India, recently appointed FCB Ulka as the Agency on Record for its creative mandate. The account will be serviced from FCB Ulka Mumbai.
The account was awarded to FCB Ulka following a multi- agency pitch.
SBI Mutual Fund (SBI MF) has completed 30 years of successful operations in India. With a widespread network spreading over 165 branches across India, SBI MF has a strong and proud lineage that traces back to the State Bank of India (SBI) – India’s largest bank. SBI MF is a Joint Venture between SBI and AMUNDI (France), one of the world’s leading fund management companies.
Commenting on the win, Nitin Karkare, CEO, FCB Ulka, said, “SBI MF is a magnanimous brand, however the category it operates in is challenging. We are delighted to bring alive the new chapter in story telling for the brand, marrying it with the trust the brand has garnered over the years. We look forward to a memorable journey and join hands in the endeavour- ‘a partner for life’ with the ‘never finished’ algorithm!”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
